ORBIMED ADVISORS LLC Q2 2017 Filing
Filed August 14, 2017
Portfolio Value
$9.5B
Holdings
135
Report Date
Q2 2017
Filing Type
13F-HR
All Holdings (135 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 101 | ALKSALKERMES PLC | 145,000 | $8.4B | 88.11% | |
| 102 | —DIMENSION THERAPEUTICS INC | 5,397,698 | $7.8B | 82.04% | |
| 103 | VRNAVERONA PHARMA PLC | 666,666 | $7.8B | 81.44% | |
| 104 | FLBFLUIDIGM CORP DEL | 1,746,100 | $7.1B | 73.94% | |
| 105 | LAB 2.75 02/01/34FLUIDIGM CORP DEL | 10,000,000 | $6.3B | 66.01% | |
| 106 | ZBHZIMMER BIOMET HLDGS INC | 49,000 | $6.3B | 65.95% | |
| 107 | SNDXSYNDAX PHARMACEUTICALS INC | 437,000 | $6.1B | 63.99% | |
| 108 | CRSPCRISPR THERAPEUTICS AG | 372,191 | $6.0B | 62.50% | |
| 109 | AGLEUSDAEGLEA BIOTHERAPEUTICS INC | 1,469,524 | $5.7B | 59.31% | |
| 110 | INFIQINFINITY PHARMACEUTICALS INC | 3,250,300 | $5.1B | 53.49% | |
| 111 | NUVAGBPNUVASIVE INC | 65,600 | $5.0B | 52.89% | |
| 112 | RDHLGBPREDHILL BIOPHARMA LTD | 564,900 | $4.9B | 51.04% | |
| 113 | SIENUSDSIENTRA INC | 483,347 | $4.7B | 49.24% | |
| 114 | HALOHALOZYME THERAPEUTICS INC | 350,000 | $4.5B | 47.03% | |
| 115 | NVTA1EURINVITAE CORP | 456,666 | $4.4B | 45.76% | |
| 116 | —SIERRA ONCOLOGY INC | 3,703,704 | $4.3B | 45.42% | |
| 117 | —INOTEK PHARMACEUTICALS CORP | 7,000,000 | $4.3B | 44.66% | |
| 118 | —TESARO INC | 30,301 | $4.2B | 44.42% | |
| 119 | GLYCEURGLYCOMIMETICS INC | 337,588 | $3.8B | 39.48% | |
| 120 | —AFFIMED N V | 1,799,700 | $3.7B | 38.67% | |
| 121 | BHCVALEANT PHARMACEUTICALS INTL | 194,900 | $3.4B | 35.34% | |
| 122 | NERVGBPMINERVA NEUROSCIENCES INC | 344,173 | $3.0B | 31.93% | |
| 123 | —OREXIGEN THERAPEUTICS INC | 5,210,000 | $2.4B | 25.61% | |
| 124 | —ROKA BIOSCIENCE INC | 893,470 | $2.3B | 24.17% | |
| 125 | XENEXENON PHARMACEUTICALS INC | 634,812 | $2.0B | 20.96% | |
| 126 | CLLSCELLECTIS S A | 66,799 | $1.7B | 18.08% | |
| 127 | —NOVELION THERAPEUTICS INC | 100,000 | $923.0M | 9.67% | |
| 128 | —BIOLINERX LTD | 1,038,600 | $878.0M | 9.20% | |
| 129 | AMRNAMARIN CORP PLC | 204,857 | $826.0M | 8.66% | |
| 130 | —MARINUS PHARMACEUTICALS INC | 567,600 | $778.0M | 8.15% | |
| 131 | —BIOMARIN PHARMACEUTICAL INC | 500,000 | $598.0M | 6.27% | |
| 132 | —BIOMARIN PHARMACEUTICAL INC | 500,000 | $556.0M | 5.83% | |
| 133 | —ALIMERA SCIENCES INC | 250,000 | $348.0M | 3.65% | |
| 134 | —XTANT MED HLDGS INC | 475,439 | $314.0M | 3.29% | |
| 135 | —MEDIGUS LTD | 60,000 | $131.0M | 1.37% |
PreviousPage 2 of 2